CARB – X ACCELERATING GLOBAL ANTIBACTERIAL INNOVATION

Objeto

Topic: Antibiotic-Resistant Bacteria.

Destination: Beginning with competitive funding calls to address unmet medical needs, CARB-X provides non-dilutive funding as well as scientific, regulatory and business support to product developers. Through life-saving innovation the goal is to keep the world prepared for dangerous bacterial infections. The CARB-X  funding rounds have three distinct product themes: oral therapeutics, vaccines for neonatal sepsis and gonorrhea products.

Budget: Not indicated.

Duration: Not indicated.

Are you interested in this call?

Estás interesado?

Llena el siguiente formulario para recibir más información: